Aducanumab: Appropriate Use Recommendations

^*Corresponding author for this work

Research output: Contribution to journal › Editorial › Academic › peer-review

Original language	English
Pages (from-to)	412-413
Number of pages	2
Journal	Journal of Prevention of Alzheimer's Disease
Volume	8
Issue number	4
Early online date	2021
DOIs	https://doi.org/10.14283/jpad.2021.45
Publication status	Published - Sep 2021

Access to Document

@article{f05d22466a0b4bcab281ceb69f446ff5,

title = "Aducanumab: Appropriate Use Recommendations",

author = "Philip Scheltens and Vijverberg, {E. G. B.}",

year = "2021",

month = sep,

doi = "10.14283/jpad.2021.45",

language = "English",

volume = "8",

pages = "412--413",

journal = "The Journal of Prevention of Alzheimer{\textquoteright}s Disease",

issn = "2274-5807",

publisher = "Springer International Publishing AG",

number = "4",

}

TY - JOUR

T1 - Aducanumab: Appropriate Use Recommendations

AU - Scheltens, Philip

AU - Vijverberg, E. G. B.

PY - 2021/9

Y1 - 2021/9

UR - http://www.scopus.com/inward/record.url?scp=85110910082&partnerID=8YFLogxK

U2 - 10.14283/jpad.2021.45

DO - 10.14283/jpad.2021.45

M3 - Editorial

C2 - 34585214

VL - 8

SP - 412

EP - 413

JO - The Journal of Prevention of Alzheimer’s Disease

JF - The Journal of Prevention of Alzheimer’s Disease

SN - 2274-5807

IS - 4

ER -